PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7354448

Further considerations on model-independent bioavailability estimation.

S Hwang·K C Kwan
View original source ↗Export metadata ↓

Abstract

Assumptions attendant to model-independent bioavailability estimation were reexamined. Particular attention was given to the situation where an intravenous reference is not available and nonrenal clearance is assumed to be constant between treatments. Under these circumstances, the previously proposed approximation was compared with other bioavailability estimators. On the basis of error analysis, a procedure was devised to yield optimal relative bioavailability estimates.

Explore related subjects

Biological AvailabilityMathematicsModels, BiologicalPharmaceutical PreparationsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Hwang, K C Kwan. 1980. Further considerations on model-independent bioavailability estimation.. https://doi.org/10.1002/jps.2600690121

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

[Timing of administration of sulfonyl urea derivatives].

In daily practice the optimal time of administration of sulphonylurea derivatives is not always clear. Administration 30 minutes prior to meals allegedly offers the advantage that an active plasma level has been reached when food enters the gastrointestinal tract. Alleged disadvantages are higher risk of hypoglycaemia and poor compliance. In publications from Medline 1966-1999 the 24-hour availability of sulphonylurea derivates was the same after administration at different times. The absorption rate of glibenclamide and tolbutamide was not affected by food. Study results concerning gliclazide were contradictory. The absorption rate of glipizide was reduced after ingestion during breakfast. In several, partly the same, small studies the findings concerning the variation of the glucose level in time in patients with type 2 diabetes mellitus were equivocal. The pharmacokinetic and pharmacodynamic evidence that sulphonylurea derivatives should be taken 30 minutes before meals appears to be so limited that in our opinion it is out-weighed by the potential risk that this advice may compromise the drug compliance of users.

Biological Availability↗